NCT06724068View on ClinicalTrials.gov

Diabetes, Insulin Resistance and Body Composition

CompletedOBSERVATIONAL

Enrollment

515

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions

Insulin Resistance, Diabetes

Interventions

OTHER

Diabetes，Insulin resistance，Control

This retrospective study uses medical records and diagnostic data from patients with type 2 diabetes and healthy controls obtained from Qianfoshan Hospital from2019 to 2022

Trial Locations (1)

250000

The First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors

lead

Xuan Song

OTHER

NCT06724068 - Diabetes, Insulin Resistance and Body Composition | Biotech Hunter | Biotech Hunter